Nuvve (NVVE) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 May, 2026Executive summary
Special Meeting scheduled for June 9, 2026, to vote on three key proposals via virtual format.
Proposals include a reverse stock split, approval of share issuance related to Omnia Venture Agreements, and potential adjournment to solicit more proxies.
Board recommends voting in favor of all proposals.
Voting matters and shareholder proposals
Proposal 1: Authorize a reverse stock split at a ratio between 1-for-2 and 1-for-40, with the exact ratio determined by the Board.
Proposal 2: Approve issuance of 19.99% or more of outstanding shares in connection with Omnia Venture Agreements, including Series B Preferred Stock conversion.
Proposal 3: Approve adjournment of the meeting if necessary to solicit additional proxies.
Board unanimously recommends voting “FOR” all proposals.
Stockholders may submit proposals or director nominations for annual meetings with advance notice as per bylaws.
Board of directors and corporate governance
Board has discretion to implement or abandon the reverse stock split within one year of approval.
No officer or director has a differing interest in the reverse stock split.
Board did not seek a fairness opinion for the Omnia Venture Agreements, citing cost and time constraints.
Latest events from Nuvve
- Q2 2026 revenue up 268%, net loss narrowed, and a 42 MW Romanian battery project was acquired.NVVE
Q2 2026 - Revenue up 49% to $1.39M, net loss narrows, but liquidity and Nasdaq risks persist.NVVE
Q1 2026 - Reverse stock split and Omnia share issuance proposals approved with quorum present.NVVE
AGM 2026 - Special meeting adjourned for lack of quorum; reconvened for June 23, 2026, with voting ongoing.NVVE
Proxy filing - Special meeting adjourned for lack of quorum; reconvened for June 15, 2026, with voting ongoing.NVVE
Proxy filing - Key votes include a reverse stock split and Omnia share issuance, both Board-recommended.NVVE
Proxy filing - Revenue and margins rose, but inventory impairment drove a higher net loss in Q4 2025.NVVE
Q4 2025 - Net loss narrowed to $1.65M in Q3 2024 as costs fell and margins improved.NVVE
Q3 2024 - Revenue fell 62% in Q2 2024, but net loss narrowed and liquidity risks remain.NVVE
Q2 2024